多药耐药菌感染患者临床资料分析与预测

发布时间：2018-06-15 18:44

本文选题：多药耐药菌 + 临床监测　；参考：《中华医院感染学杂志》2016年20期

【摘要】：目的分析医院多药耐药菌的流行特点,为降低和控制多药耐药菌感染提供依据。方法选取2013年1月-2014年12月7 443例住院患者送检标本,采用法国梅里埃公司VITEK-2Compact全自动细菌分析仪进行相关检测分析,数据采用SPSS17.0统计软件进行分析。结果 7 443例住院患者送检标本,1769例检测阳性,阳性率为23.77%;检出多药耐药菌666株,检出率为37.65%;多药耐药菌以产ESBLs大肠埃希菌为主320株占48.05%,其次为多药耐药鲍氏不动杆菌152株占22.08%;在科室分布中,多药耐药菌具有明显科室特点,如ICU的鲍氏不动杆菌占57.89%、外科系统的产ESBLs肠杆菌占45.94%、骨科、烧伤科等具有创面的MRSA占48.84%。结论多药耐药菌感染可根据感染部位、患者基础情况以及入住科室进行预测。
[Abstract]:Objective to analyze the epidemic characteristics of multidrug resistant bacteria (MDR) in hospital and to provide evidence for reducing and controlling the infection of MDR. Methods from January 2013 to December 2014, 7,443 inpatients were selected and analyzed by VITEK-2Compact automatic bacterial analyzer of Merier Company of France. The data were analyzed by SPSS 17.0 software. Results 1769 samples of 7 443 inpatients were tested positive, the positive rate was 23.777.666 strains of multidrug resistant bacteria were detected. The detection rate was 37.65%, and 320 strains of ESBLs-producing Escherichia coli accounted for 48.05, followed by 152 strains of Acinetobacter baumannii (22.08%). For example, Acinetobacter baumannii accounted for 57.89 in ICU, ESBLs-producing Enterobacter spp accounted for 45.94 in surgical system, MRSA with wounds in orthopedics and burn department accounted for 48.84. Conclusion the infection of multidrug resistant bacteria can be predicted according to the site of infection, the basic condition of patients and the department.
【作者单位】：蚌埠市第三人民医院感染管理科;
【基金】：安徽省高等学校省级自然科学研究基金资助项目(KJ2013Z150)
【分类号】：R446.5

【相似文献】